Clinical Trial Update: Reliability, Safety and Usability of the Transplantation Sensor System Combined With Myfortic® in Adult Kidney Transplant Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the reliability, safety and usability of the Transplantation Sensor System combined with Myfortic in adult kidney transplant patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• MYFORTIC (MYCOPHENOLIC ACID)
• Transplantation Sensor System

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Detection Accuracy, Patient Compliance | Phase 2 | Status: COMPLETED